Bridgebio Pharma, Inc. · NASDAQ:BBIO
Trimarchi Thomas sold 13,651 Bridgebio Pharma, Inc. shares (Form 4)
Traded May 16 to May 18, 2026 · Filed May 19, 2026
From May 16 to May 18, 2026, Trimarchi Thomas (President and CFO) sold 13,651 Bridgebio Pharma, Inc. shares at an average US$65.08 for US$888K under a trading plan, leaving 359,194 shares. Filed May 19, 2026 (Form 4).
- Sold
- 13,651 shares
- Price
- US$65.08 average (US$64.82 to US$65.95)
- Value
- US$888K
- Holding after
- 359,194 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President and CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 16, 2026 | Common Stock | Shares withheld for tax | 22,781 | US$66.13 | 372,845 | Direct |
| May 18, 2026 | Common Stock | Sale | 10,456 | US$64.82 | 362,389 | Direct |
| May 18, 2026 | Common Stock | Sale | 3,195 | US$65.95 | 359,194 | Direct |
Source
Related
- Bridgebio Pharma, Inc.
- Trimarchi Thomas
- Bridgebio Pharma, Inc. shareholders
- Form 4 · Trimarchi Thomas · Aug 18, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Aug 18, 2026
- Form 4 · Apuli Maricel · Aug 18, 2026
- Schedule 13D/A · KKR Genetic Disorder L.P. · Aug 17, 2026